Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 1;36(1):144-146.
doi: 10.1681/ASN.0000000569. Epub 2024 Nov 5.

Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device

Christopher J Pino  1 , Kimberly A Johnston, Angela J Westover, H David Humes
Affiliations

Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device

Christopher J Pino et al. J Am Soc Nephrol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/JSN/E950.

Similar articles

See all similar articles

Cited by

References

    1. Tumlin J Wali R Williams W, et al. . Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol. 2008;19(5):1034–1040. doi:10.1681/ASN.2007080895 - DOI - PMC - PubMed
    1. Tumlin JA Galphin CM Tolwani AJ, et al. .; SCD Investigator Group. A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS One. 2015;10(8):e0132482. doi:10.1371/journal.pone.0132482 - DOI - PMC - PubMed
    1. Jun M Heerspink HJ Ninomiya T, et al. . Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2010;5(6):956–963. doi:10.2215/CJN.09111209 - DOI - PMC - PubMed
    1. Humes HD, Buffington D, Westover AJ, Roy S, Fissell WH. The bioartificial kidney: current status and future promise. Pediatr Nephrol. 2014;29(3):343–351. doi:10.1007/s00467-013-2467-y - DOI - PubMed
    1. Humes HD, Sobota JT, Ding F, Song JH.; RAD Investigator Group. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif. 2010;29(2):183–190. doi:10.1159/000245645 - DOI - PubMed

LinkOut - more resources